البحث عن طبيب

Kymberly D. Watt, M.D.

  1. Gastroenterologist
  2. Internist
  3. Transplant Hepatologist
طلب موعد

المنشورات

  1. Watt KD. Michael F. Sorrell, MD. Hepatology. 2024 Nov 1; 80 (5):1301-1302 Epub 2024 July 24
    View PubMed
  2. Mouchli MA, Osman MK, Busebee B, Taner T, Heimbach JK, Eaton J, Mousa O, Cole K, Watt KD. Long term (15 year) complications & outcomes after liver transplantation for primary sclerosing cholangitis: Impact of donor and recipient factors. Liver Transpl. 2024 Oct 28 [Epub ahead of print]
    View PubMed
  3. Satapathy SK, Elwir S, Brandman D, Smith C, Jiang Y, Vanatta J, Ha NB, Cheung AC, Bhat M, Patel P, Siddiqui MS, Rinella ME, Watt KD. Risk Stratification for Chronic Kidney Disease After Liver Transplant for Metabolic Dysfunction-associated Steatohepatitis (MASH) Cirrhosis: Results From the NailMASH Consortium. Transplantation. 2024 Oct 22 [Epub ahead of print]
    View PubMed
  4. Durand F, Watt KD. "Out With the Old, In With the New": Donor Risk Evolution Is Upon Us. Transplantation. 2024 Oct 15 [Epub ahead of print]
    View PubMed
  5. Busebee B, Watt KD, Dupuy-McCauley K, DuBrock H. Sleep disturbances in chronic liver disease. Liver Transpl. 2024 Oct 1; 30 (10):1058-1071 Epub 2024 Mar 27
    View PubMed
  6. Busebee BT, Chin JY, Mara K, Johnson B, Takahashi N, Majumder S, Watt KD. Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas After Liver Transplantation. Clin Transplant. 2024 Oct; 38 (10):e15431
    View PubMed
  7. Gong P, Zhang J, Huang C, Lok UW, Tang S, Liu H, DeRuiter R, Peterson K, Petersen K, Knoll K, Robinson K, Watt K, Callstrom M, Chen S. Novel Quantitative Liver Steatosis Assessment Method With Ultrasound Harmonic Imaging. J Ultrasound Med. 2024 Sep 24 Epub 2024 Sept 24
    View PubMed
  8. Chiu CY, Sampathkumar P, Brumble LM, Vikram HR, Watt KD, Beam E. Hepatitis B Vaccine Compliance, Serologic Response, and Durability in Adult Thoracic Organ Transplant Recipients. Clin Transplant. 2024 Sep; 38 (9):e15464
    View PubMed
  9. Schmidt K, Spann A, Khan MQ, Izzy M, Watt KD. Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation. Transplantation. 2024 Aug 1; 108 (8):1689-1699 Epub 2023 Dec 07
    View PubMed
  10. Chiu CY, Brumble LM, Vikram HR, Watt KD, Beam E. Hepatitis B Virus Reactivation in Non-Liver Solid Organ Transplantation: Incidence and Risk Analysis. Clin Transplant. 2024 Jul; 38 (7):e15389
    View PubMed
  11. Fipps DC, Nguyen T, Meyer R, Smith B, Roden R, Clark MM, Watt KD, Jowsey-Gregoire SG. The Frequency and Impact of Adverse Childhood Experiences on Mood, Alcohol Relapse, and Outcomes in Liver Transplantation: A Retrospective Cohort Study. J Acad Consult Liaison Psychiatry. 2024 Jun 26 Epub 2024 June 26
    View PubMed
  12. Watt KD, Rolak S, Foley DP, Plichta JK, Pruthi S, Farr D, Zwald FO, Carvajal RD, Dudek AZ, Sanger CB, Rocco R, Chang GJ, Dizon DS, Langstraat CL, Teoh D, Agarwal PK, Al-Qaoud T, Eggener S, Kennedy CC, D'Cunha J, Mohindra NA, Stewart S, Habermann TH, Schuster S, Lunning M, Shah NN, Gertz MA, Mehta J, Suvannasankha A, Verna E, Farr M, Blosser CD, Hammel L, Al-Adra DP. Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion. Transplantation. 2024 May 21 [Epub ahead of print]
    View PubMed
  13. Rolak SC, Yetmar ZA, Lahr BD, Beam E, Razi S, Watt K, Yang L, Aqel BA, Mahmood M. Risk Factors for Surgical-site Infections After Liver Transplant: Does Perioperative Antibiotic Regimen Matter? Transplantation. 2024 May 1; 108 (5):1179-1188 Epub 2023 Dec 04
    View PubMed
  14. Rolak S, Elhawary A, Diwan T, Watt KD. Futility and poor outcomes are not the same thing: A clinical perspective of refined outcomes definitions in liver transplantation. Liver Transpl. 2024 Apr 1; 30 (4):421-430 Epub 2024 Jan 22
    View PubMed
  15. Fipps DC, Meyer R, Woods J, Watt K, Schneekloth T, Gifford J, Kolla BP. Clinical Utility and Impact of Phosphatidylethanol Testing in Liver Transplantation Evaluations. J Acad Consult Liaison Psychiatry. 2024 Mar-Apr; 65 (2):157-166 Epub 2023 Dec 01
    View PubMed
  16. Busebee B, Myhre L, Mara K, Aqel B, Taner T, Watt KD. De novo hepatitis B infection following liver transplantation with core antibody positive grafts: The role of surface antibody status in guiding long-term prophylaxis. Clin Transplant. 2024 Feb; 38(2):e15263.
    View PubMed
  17. Bazerbachi F, Baroud S, Levy MJ, Maselli DB, Vargas EJ, Bofill-Garcia A, Law RJ, Chandrasekhara V, Storm AC, Gleeson FC, Rajan E, Iyer PG, Watt KD, Abu Dayyeh BK. Celiac artery mesenteric fat measurement with endosonography (CAMEUS) reliably correlates with obesity and related comorbidities. Gastroenterol Rep (Oxf). 2024; 12:goae039 Epub 2024 Apr 26
    View PubMed
  18. Watt KD, Khan MQ. Reply: More on non-alcohol/non-metabolic dysfunction-associated steatohepatitis. Hepatology. 2023 Dec 26 [Epub ahead of print]
    View PubMed
  19. Siddiqui MS, Muthiah M, Satapathy SK, Patidar KR, Bhat M, Brandman D, Watt KD, Rinella M. Defining an approach for therapeutic strategies in metabolic dysfunction-associated steatotic liver disease after liver transplantation. Hepatology. 2023 Dec 13 [Epub ahead of print]
    View PubMed
  20. Allen A, Berg T, Charlton M, Shapiro D, Watt K, Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gomez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023 Dec 1; 78 (6):1966-1986 Epub 2023 June 24
    View PubMed
  21. Khan MQ, Hassan S, Lizaola-Mayo BC, Bhat M, Watt KD. Navigating the "specific etiology" steatohepatitis category: Evaluation and management of nonalcoholic/nonmetabolic dysfunction-associated steatohepatitis. Hepatology. 2023 Nov 7 Epub 2023 Nov 07
    View PubMed
  22. Kow AWC, Liu J, Patel MS, De Martin E, Reddy MS, Soejima Y, Syn N, Watt K, Xia Q, Saraf N, Kamel R, Nasralla D, McKenna G, Srinvasan P, Elsabbagh AM, Pamecha V, Palaniappan K, Mas V, Tokat Y, Asthana S, Cherukuru R, Egawa H, Lerut J, Broering D, Berenguer M, Cattral M, Clavien PA, Chen CL, Shah S, Zhu ZJ, Emond J, Ascher N, Rammohan A, Bhangui P, Rela M, Kim DS, Ikegami T, ILTS-iLDLT-LTSI SFSS Working Group. Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference. Transplantation. 2023 Oct 1; 107 (10):2226-2237 Epub 2023 Sept 25
    View PubMed
  23. Liu A, Angirekula M, Elhawary A, Mara K, Kulai T, Leise M, Watt KD. Progression of fibrosis in liver transplant recipients with hepatitis C before and after sustained virologic response. Clin Transplant. 2023 Oct; 37 (10):e15050 Epub 2023 June 17
    View PubMed
  24. Watt KD, Paul S, Khan MQ, Siddiqui M, Lam J, Diwan TS, Camilleri M. Obesity management for the hepatologist-What to do, how to do it and why? Hepatology. 2023 Sep 19 Epub 2023 Sept 19
    View PubMed
  25. Cho J, Johnson BD, Watt KD, Niven AS, Shin J, Kim CH. Alterations in pulmonary vasomotor modulators post aerobic exercise training in non-alcoholic fatty liver disease. Respir Physiol Neurobiol. 2023 Aug; 314:104089 Epub 2023 June 01
    View PubMed
  26. Tsochatzis EA, Watt KD, VanWagner LB, Verna EC, Berzigotti A. Evaluation of recipients with significant comorbidity - Patients with cardiovascular disease. J Hepatol. 2023 Jun; 78 (6):1089-1104
    View PubMed
  27. Rinella ME, Satapathy SK, Brandman D, Smith C, Elwir S, Xia J, Gibson M, Figueredo C, Angirekula M, Vanatta JM, Sarwar R, Jiang Y, Gregory D, Agostini T, Ko J, Podila P, Gallo G, Watt KD, Siddiqui MS. Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH Consortium. Clin Gastroenterol Hepatol. 2023 Feb; 21 (2):445-455.e2 Epub 2022 Feb 18
    View PubMed
  28. Robateau Colon A, Higgins E, Boire N, Cummins N, Watt KD. Non-tuberculous mycobacteria infection presenting as a hepatic allograft abscess. IDCases. 2023; 31:e01722 Epub 2023 Feb 17
    View PubMed
  29. Cajigas HR, Burger CD, Cartin-Ceba R, DuBrock H, Swanson K, Vargas HE, Keaveny AP, Watt KD, Krowka M. Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry. Mayo Clin Proc. 2022 Dec; 97 (12):2236-2247 Epub 2022 Nov 03
    View PubMed
  30. Cho J, Johnson BD, Watt KD, Niven AS, Yeo D, Kim CH. Exercise training attenuates pulmonary inflammation and mitochondrial dysfunction in a mouse model of high-fat high-carbohydrate-induced NAFLD. BMC Med. 2022 Nov 8; 20 (1):429 Epub 2022 Nov 08
    View PubMed
  31. Mercado LA, Bhangu HK, Calderon E, Mathur AK, Aqel B, Musto KR, Watt KD, Rosen CB, Bolan C, LeGout JD, Taner CB, Harnois DM, Croome KP. DCD Liver Grafts Can Safely Be Used for Recipients With Grade I-II Portal Vein Thrombosis: A Multicenter Analysis. Transplant Direct. 2022 Nov; 8 (11):e1392 Epub 2022 Oct 07
    View PubMed
  32. Gong P, Huang C, Lok UW, Tang S, Ling W, Zhou C, Yang L, Watt KD, Callstrom M, Chen S. Improved Ultrasound Attenuation Estimation with Non-uniform Structure Detection and Removal. Ultrasound Med Biol. 2022 Nov; 48 (11):2292-2301 Epub 2022 Aug 26
    View PubMed
  33. Doycheva I, Erickson D, Watt KD. Growth hormone deficiency and NAFLD: An overlooked and underrecognized link. Hepatol Commun. 2022 Sep; 6 (9):2227-2237 Epub 2022 June 28
    View PubMed
  34. de Rosner-van Rosmalen M, Adelmann D, Berlakovich GA, Francoz C, Selzner N, Berenguer M, Watt KD, Man NK, Burra P, Pai SL. Women Leadership in Liver Transplantation-Results of an International Survey. Transplantation 2022 Sep 1; 106 (9):1699-1702 Epub 2022 Aug 19
    View PubMed
  35. Nasser-Ghodsi N, Mara K, Allen AM, Watt KD. Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy. Clin Transplant. 2022 Aug; 36 (8):e14714 Epub 2022 June 02
    View PubMed
  36. Chesdachai S, Udompap P, Yetmar ZA, Watt KD, Aqel BA, Yang L, Beam E. Infectious complications in acute graft-versus-host disease after liver transplantation. Transpl Infect Dis. 2022 Aug; 24 (4):e13843 Epub 2022 June 01
    View PubMed
  37. Singh N, Watt KD, Bhanji RA. The fundamentals of sex-based disparity in liver transplantation: Understanding can lead to change. Liver Transpl. 2022 Aug; 28 (8):1367-1375 Epub 2022 Apr 25
    View PubMed
  38. Cho J, Johnson BD, Watt KD, Kim CH. Greater Muscular Strength Is Associated with a Lower Risk of Pulmonary Dysfunction in Individuals with Non-Alcoholic Fatty Liver Disease. J Clin Med. 2022 Jul 17; 11 (14) Epub 2022 July 17
    View PubMed
  39. Richardson B, Khan MQ, Brown SA, Watt KD, Izzy M. Personalizing Diabetes Management in Liver Transplant Recipients: The New Era for Optimizing Risk Management. Hepatol Commun. 2022 Jun; 6 (6):1250-1261 Epub 2021 Dec 17
    View PubMed
  40. Thompson SM, Suman G, Torbenson MS, Chen ZE, Jondal DE, Patra A, Ehman EC, Andrews JC, Fleming CJ, Welch BT, Kurup AN, Roberts LR, Watt KD, Truty MJ, Cleary SP, Smoot RL, Heimbach JK, Tran NH, Mahipal A, Yin J, Zemla T, Wang C, Fogarty Z, Jacobson M, Kemp BJ, Venkatesh SK, Johnson GB, Woodrum DA, Goenka AH. PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and (68) Ga-PSMA-11 PET Using Cyclotron-Produced (68) Ga. Hepatol Commun. 2022 May; 6 (5):1172-1185 Epub 2021 Nov 15
    View PubMed
  41. Lok UW, Gong P, Huang C, Tang S, Zhou C, Yang L, Watt KD, Callstrom M, Trzasko JD, Chen S. Reverberation clutter signal suppression in ultrasound attenuation estimation using wavelet-based robust principal component analysis. Phys Med Biol. 2022 Apr 28; 67 (9)
    View PubMed
  42. Cheung AC, Juran BD, Schlicht EM, McCauley BM, Atkinson EJ, Moore R, Heimbach JK, Watt KD, Wu TT, LaRusso NF, Gores GJ, Sun Z, Lazaridis KN. DNA methylation profile of liver tissue in end-stage cholestatic liver disease. Epigenomics. 2022 Apr; 14 (8):481-497 Epub 2022 Apr 27
    View PubMed
  43. Pai SL, Chadha RM, Logvinov II, Brigham TJ, Watt KD, Li Z, Palmer WC, Blackshear JL, Aniskevich S. Preoperative echocardiography as a prognostic tool for liver transplant in patients with hypertrophic cardiomyopathy. Clin Transplant. 2022 Feb; 36 (2):e14538 Epub 2021 Nov 29
    View PubMed
  44. Colmenero J, Berenguer M, Watt KD. The ILTS-SETH Consensus Conference on Extrahepatic Cancer and Liver Transplantation: Paving the Way. Transplantation. 2022 Jan 1; 106 (1):e1-e2
    View PubMed
  45. Colmenero J, Tabrizian P, Bhangui P, Pinato DJ, Rodriguez-Peralvarez ML, Sapisochin G, Bhoori S, Pascual S, Senzolo M, Al-Adra D, Herrero JI, Petrowsky H, Dawson LA, Hosni A, Kutzke JL, Gastaca M, Watt KD. De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference. Transplantation. 2022 Jan 1; 106 (1):e30-e45
    View PubMed
  46. Lok UW, Gong P, Huang C, Tang S, Zhou C, Yang L, Watt KD, Callstrom M, Trzasko JD, Chen S. Robust principal component analysis with wavelet-based sparsity promotion to mitigate reverberation clutters for ultrasound attenuation estimation. IEEE International Ultrasonics Symposium, IUS. 2022; 2022-October:9957606
  47. Mendoza YP, Becchetti C, Watt KD, Berzigotti A. Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. Semin Liver Dis. 2021 Nov; 41 (4):448-460 Epub 2021 July 09
    View PubMed
  48. King RL, Khurana A, Mwangi R, Fama A, Ristow KM, Maurer MJ, Macon WR, Ansell SM, Bennani NN, Kudva YC, Walker RC, Watt KD, Schwab TR, Kushwaha SS, Cerhan JR, Habermann TM. Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria. Hemasphere. 2021 Oct; 5 (10):e640 Epub 2021 Sept 06
    View PubMed
  49. Watt KD, Heimbach JK, Rizk M, Jaruvongvanich P, Sanchez W, Port J, Venkatesh SK, Bamlet H, Tiedtke K, Malhi H, Acosta Cardenas A, Grothe K, Clark M, Mundi MS, Abu Dayyeh BK. Efficacy and Safety of Endoscopic Balloon Placement for Weight Loss in Patients With Cirrhosis Awaiting Liver Transplantation. Liver Transpl. 2021 Sep; 27 (9):1239-1247 Epub 2021 July 26
    View PubMed
  50. Nasser-Ghodsi N, Mara K, Watt KD. De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations. Hepatology. 2021 Aug; 74 (2):1003-1013 Epub 2021 June 21
    View PubMed
  51. Gong P, Song P, Huang C, Lok UW, Tang S, Zhou C, Yang L, Watt KD, Callstrom M, Chen S. Noise Suppression for Ultrasound Attenuation Coefficient Estimation Based on Spectrum Normalization. IEEE Trans Ultrason Ferroelectr Freq Control. 2021 Aug; 68 (8):2667-2674 Epub 2021 July 26
    View PubMed
  52. Fipps DC, Goetze RE, Clark MM, Mara K, Watt KD, Jowsey-Gregoire SG, Heimbach JK, Grothe K. Liver Transplantation After Bariatric Surgery: a Clinical Cohort Study. Obes Surg. 2021 Aug; 31 (8):3700-3706 Epub 2021 May 22
    View PubMed
  53. Yohanathan L, Corsini Campioli C, Campioli CC, Mousa OY, Friedman DZP, Shah V, Ramkissoon R, Hines AS, Kamath PS, Razonable RR, Badley AD, DeMartino ES, Joyner MJ, Graham R, Vergidis P, Simonetto DA, Sanchez W, Taner T, Heimbach JK, Beam E, Leise MD. Liver transplantation for acute liver failure in a SARS-CoV-2 PCR-positive patient. Am J Transplant. 2021 Aug; 21 (8):2890-2894 Epub 2021 May 05
    View PubMed
  54. Bhanji RA, Watt KD. Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation. Liver Transpl. 2021 Jul; 27 (7):1041-1053
    View PubMed
  55. Abu Rmilah A, Fencl R, Watt K, Krowka M, Wiesner R, Murray D, Nyberg S, Leise M. Association of alpha 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation. Transplantation. 2021 Jul 1; 105 (7):1576-1584
    View PubMed
  56. Haffar S, Izzy M, Habib H, Sugihara T, Li DK, Sharma A, Wang Z, Murad MH, Watt KD, Bazerbachi F. Liver chemistries in glycogenic hepatopathy associated with type 1 diabetes mellitus: A systematic review and pooled analysis. Liver Int. 2021 Jul; 41 (7):1545-1555 Epub 2021 Feb 28
    View PubMed
  57. Izzy M, Angirekula M, Abu Dayyeh BK, Bazerbachi F, Watt KD. Bariatric surgery proves long-term benefit in patients with cirrhosis. Gastroenterol Rep (Oxf). 2021 Jun; 9 (3):252-256 Epub 2020 Nov 24
    View PubMed
  58. Izzy M, Soldatova A, Sun X, Angirekula M, Mara K, Lin G, Watt KD. Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria. Liver Transpl. 2021 Jun; 27 (6):876-886
    View PubMed
  59. Brown SA, Izzy M, Watt KD. Pharmacotherapy for Weight Loss in Cirrhosis and Liver Transplantation: Translating the Data and Underused Potential. Hepatology. 2021 May; 73 (5):2051-2062
    View PubMed
  60. Nitski O, Azhie A, Qazi-Arisar FA, Wang X, Ma S, Lilly L, Watt KD, Levitsky J, Asrani SK, Lee DS, Rubin BB, Bhat M, Wang B. Long-term mortality risk stratification of liver transplant recipients: real-time application of deep learning algorithms on longitudinal data. Lancet Digit Health. 2021 May; 3 (5):e295-e305 Epub 2021 Apr 12
    View PubMed
  61. Yohanathan L, Corsini CG, Ramkissoon R, Mousa O, Watt KD, Friedman DZP, Shah VH, Hines AS, Kamath PS, Razonable RR, Badley AD, DeMartino ES, Joyner MJ, Vergidis P, Simonetto DA, Sanchez W, Taner T, Heimbach JK, Beam E, Leise MD. Liver Transplantation for Acute Liver Failure in a Patient with COVID-19 Infection and SARS-CoV-2 PCR Positivity American Journal of Transplantation. 2021.
  62. Sehrawat TS, Arab JP, Liu M, Amrollahi P, Wan M, Fan J, Nakao Y, Pose E, Navarro-Corcuera A, Dasgupta D, Liao CY, He L, Mauer AS, Avitabile E, Ventura-Cots M, Bataller RA, Sanyal AJ, Chalasani NP, Heimbach JK, Watt KD, Gores GJ, Gines P, Kamath PS, Simonetto DA, Hu TY, Shah VH, Malhi H. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis. Hepatology. 2021 Feb; 73 (2):571-585 Epub 2020 Oct 30
    View PubMed
  63. Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Verna E, Locke J, D'Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta J, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qaoud T, Eggener S, Richgels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement. Am J Transplant. 2021 Feb; 21 (2):460-474 Epub 2020 Oct 23
    View PubMed
  64. Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Verna E, Locke J, D'Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta J, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qaoud T, Eggener S, Richgels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement. Am J Transplant. 2021 Feb; 21 (2):475-483 Epub 2020 Oct 10
    View PubMed
  65. Bazerbachi F, Vargas EJ, Rizk M, Maselli DB, Mounajjed T, Venkatesh SK, Watt KD, Port JD, Basu R, Acosta A, Hanouneh I, Gara N, Shah M, Mundi M, Clark M, Grothe K, Storm AC, Levy MJ, Abu Dayyeh BK. Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2021 Jan; 19 (1):146-154.e4 Epub 2020 Apr 30
    View PubMed
  66. Bhanji RA, Saiman Y, Watt KD. Nonalcoholic Steatohepatitis, Sarcopenia, and Liver Transplantation. Clin Liver Dis (Hoboken). 2021 Jan; 17 (1):2-5 Epub 2021 Feb 01
    View PubMed
  67. Tse CS, Yang JD, Mousa OY, Nelson KM, Pungpapong S, Keaveny A, Aqel BA, Vargas H, Dickson RC, Watt K, Gores GJ, Roberts LR, Leise MD. Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C. Transplant Direct. 2021 Jan; 7(1):e635. Epub 2020 Dec 08.
    View PubMed
  68. Gong P, Zhou C, Song P, Huang C, Lok UW, Tang S, Watt K, Callstrom M, Chen S. Ultrasound Attenuation Estimation in Harmonic Imaging for Robust Fatty Liver Detection. Ultrasound Med Biol. 2020 Nov; 46 (11):3080-3087 Epub 2020 Aug 06
    View PubMed
  69. Sivaraj S, Chan A, Pasini E, Chen E, Lawendy B, Verna E, Watt K, Bhat M. Enteric dysbiosis in liver and kidney transplant recipients: a systematic review. Transpl Int. 2020 Oct; 33 (10):1163-1176 Epub 2020 Aug 05
    View PubMed
  70. Nasser-Ghodsi N, Plevak MF, Dierkhising RA, Angirekula M, Izzy M, Lerman A, Watt KD. Peripheral Endothelial Function as a Marker of Systemic Vasodilation in End-stage Liver Disease: Results of a Pilot Study. Transplant Direct. 2020 May; 6 (5):e546 Epub 2020 Apr 09
    View PubMed
  71. Spann A, Yasodhara A, Kang J, Watt K, Wang B, Goldenberg A, Bhat M. Applying Machine Learning in Liver Disease and Transplantation: A Comprehensive Review. Hepatology. 2020 Mar; 71 (3):1093-1105 Epub 2020 Mar 06
    View PubMed
  72. Bhat M, Pasini E, Das A, Baciu C, Angeli M, Humar A, Watt KD, Allard J. Diabetogenic Effects of Immunosuppression: An Integrative Analysis. Transplantation. 2020 Jan; 104 (1):211-221
    View PubMed
  73. Izzy M, VanWagner LB, Lin G, Altieri M, Findlay JY, Oh JK, Watt KD, Lee SS, Cirrhotic Cardiomyopathy Consortium. Redefining Cirrhotic Cardiomyopathy for the Modern Era. Hepatology. 2020 Jan; 71 (1):334-345 Epub 2019 Oct 11
    View PubMed
  74. Bhanji RA, Montano-Loza AJ, Watt KD. Sarcopenia in Cirrhosis: Looking Beyond the Skeletal Muscle Loss to See the Systemic Disease. Hepatology. 2019 Dec; 70 (6):2193-2203
    View PubMed
  75. Allen AM, Therneau TM, Mara KC, Larson JJ, Watt KD, Hayes SN, Kamath PS. Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study. Am J Gastroenterol. 2019 Nov; 114 (11):1764-1771
    View PubMed
  76. Schneider S, Diaz Jaime F, Mara K, Dierkhising R, Heimbach J, Watt KD, Berenguer M. Long-term outcomes of the octogenarian donor liver recipient: The era of the new centurion. Clin Transplant. 2019 Aug; 33 (8):e13629 Epub 2019 July 04
    View PubMed
  77. Iyer VN, Saberi B, Heimbach JK, Larson JJ, Raghavaiah S, Ditah I, Swanson K, Kamath PS, Watt KD, Taner T, Krowka MJ, Leise MD. Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia in the United States. Transplantation. 2019 Jul; 103 (7):1418-1424
    View PubMed
  78. Doycheva I, Watt KD, Gulamhusein AF. Autoimmune hepatitis: Current and future therapeutic options. Liver Int. 2019 Jun; 39 (6):1002-1013 Epub 2019 Mar 07
    View PubMed
  79. Drinane M, Jing Wang X, Wang XJ, Watt K. Sofosbuvir and Ribavirin Eradication of Refractory Hepatitis E in an Immunosuppressed Kidney Transplant Recipient. Hepatology. 2019 May; 69 (5):2297-2299 Epub 2019 Mar 08
    View PubMed
  80. Izzy M, VanWagner LB, Lee SS, Altieri M, Angirekula M, Watt KD. Understanding and managing cardiovascular outcomes in liver transplant recipients. Curr Opin Organ Transplant. 2019 Apr; 24 (2):148-155
    View PubMed
  81. Bhanji RA, Takahashi N, Moynagh MR, Narayanan P, Angirekula M, Mara KC, Dierkhising RA, Watt KD. The evolution and impact of sarcopenia pre- and post-liver transplantation. Aliment Pharmacol Ther. 2019 Mar; 49 (6):807-813 Epub 2019 Feb 03
    View PubMed
  82. Bhat M, Mara K, Dierkhising R, Watt KD. Gender, Race and Disease Etiology Predict De Novo Malignancy Risk After Liver Transplantation: Insights for Future Individualized Cancer Screening Guidance. Transplantation. 2019 Jan; 103 (1):91-100
    View PubMed
  83. Shiffman M, Freilich B, Vuppalanchi R, Watt K, Chan JL, Spada A, Hagerty DT, Schiff E. Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2019 Jan; 49 (1):64-73 Epub 2018 Nov 14
    View PubMed
  84. Germani G, Laryea M, Rubbia-Brandt L, Egawa H, Burra P, O'Grady J, Watt KD. Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation. Transplantation. 2019 Jan; 103 (1):57-67
    View PubMed
  85. Bhanji RA, Narayanan P, Moynagh MR, Takahashi N, Angirekula M, Kennedy CC, Mara KC, Dierkhising RA, Watt KD. Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease. Liver Transpl. 2019 Jan; 25 (1):14-24
    View PubMed
  86. Narayanan P, Mara K, Izzy M, Dierkhising R, Heimbach J, Allen AM, Watt KD. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation. Transplantation. 2019 Jan; 103 (1):e14-e21
    View PubMed
  87. Schneekloth TD, Hitschfeld MJ, Petterson TM, Narayanan P, Niazi SK, Jowsey-Gregoire SG, Thusius NJ, Vasquez AR, Kremers WK, Watt KD, Rummans TA. Psychosocial Risk Impacts Mortality in Women After Liver Transplantation. Psychosomatics. 2019 Jan - Feb; 60 (1):56-65 Epub 2018 June 27
    View PubMed
  88. Bazerbachi F, Haffar S, Wang Z, Cabezas J, Arias-Loste MT, Crespo J, Darwish-Murad S, Ikram MA, Olynyk JK, Gan E, Petta S, Berzuini A, Prati D, de Ledinghen V, Wong VW, Del Poggio P, Chavez-Tapia NC, Chen YP, Cheng PN, Yuen MF, Das K, Chowdhury A, Caballeria L, Fabrellas N, Gines P, Kumar M, Sarin SK, Conti F, Andreone P, Sirli R, Cortez-Pinto H, Carvalhana S, Sugihara T, Kim SU, Parikh P, Chayama K, Corpechot C, Kim KM, Papatheodoridis G, Alsebaey A, Kamath PS, Murad MH, Watt KD. Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals. Clin Gastroenterol Hepatol. 2019 Jan; 17 (1):54-64.e1 Epub 2018 Sept 07
    View PubMed
  89. Snipelisky D, Shipman J, Olson N, Pellikka P, Aqel B, McCully R, Watt K. Low to Intermediate Dose Atropine Administration During Dobutamine Stress Echocardiography in the Pre-Liver Transplant Population. Prog Transplant. 2018 Dec; 28 (4):361-367 Epub 2018 Sept 16
    View PubMed
  90. Bhat V, Tazari M, Watt KD, Bhat M. New-Onset Diabetes and Preexisting Diabetes Are Associated With Comparable Reduction in Long-Term Survival After Liver Transplant: A Machine Learning Approach. Mayo Clin Proc. 2018 Dec; 93 (12):1794-1802
    View PubMed
  91. Zhang N, Jin W, Zhou S, Yang JD, Harmsen WS, Giama NH, Wongjarupong N, Heimbach JK, Watt KD, Malhi H, Therneau TM, Roberts LR. Hypothyroidism is associated with worse outcomes of hepatocellular carcinoma patients after liver transplantation. Cancer Med. 2018 Dec; 7 (12):5870-5878 Epub 2018 Nov 19
    View PubMed
  92. Izzy M, Oh J, Watt KD. Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander. Hepatology. 2018 Nov; 68 (5):2008-2015 Epub 2018 Oct 13
    View PubMed
  93. Bazerbachi F, Haffar S, Hussain MT, Vargas EJ, Watt KD, Murad MH, Chari S, Abu Dayyeh BK. Systematic review of acute pancreatitis associated with interferon-alpha or pegylated interferon-alpha: Possible or definitive causation? Pancreatology. 2018 Oct; 18 (7):691-699 Epub 2017 Sept 21
    View PubMed
  94. Aqel B, Leise M, Vargas HE, Watt KD, Keaveny AP, Zhang N, Pungpapong S. Multicenter Experience using Ledipasvir/Sofosbuvir +/- RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment. Ann Hepatol. 2018 Sep - Oct; 17 (5):815-821
    View PubMed
  95. Bhat M, Mara K, Dierkhising R, Watt KDS. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients. Mayo Clin Proc. 2018 Sep; 93 (9):1236-1246 Epub 2018 July 29
    View PubMed
  96. Aqel B, Leise M, Vargas HE, Watt KD, Keaveny AP, Zhang N, Zhang N, Pungpapong S. Multicenter Experience using Ledipasvir/Sofosbuvir +/- RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment. Ann Hepatol. 2018 Aug 24; 17 (5):815-821
    View PubMed
  97. Zamora-Valdes D, Watt KD, Kellogg TA, Poterucha JJ, Di Cecco SR, Francisco-Ziller NM, Taner T, Rosen CB, Heimbach JK. Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy. Hepatology. 2018 Aug; 68 (2):485-495 Epub 2018 May 14
    View PubMed
  98. Welch BT, Schmitz JJ, Kurup AN, Atwell TD, Callstrom MR, Frey G, Paz-Fumagalli R, Allen A, Watt K, Heimbach J, Schmit GD. Feasibility and outcomes of percutaneous thermal ablation of hepatocellular carcinoma in a transplanted allograft. Abdom Radiol (NY). 2018 Jun; 43 (6):1478-1481
    View PubMed
  99. Mouchli MA, Singh S, Boardman L, Bruining DH, Lightner AL, Rosen CB, Heimbach JK, Hasan B, Poterucha JJ, Watt KD, Kane SV, Raffals LE, Loftus EV. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Inflamm Bowel Dis. 2018 Apr 23; 24 (5):1074-1081
    View PubMed
  100. Doycheva I, Issa D, Watt KD, Lopez R, Rifai G, Alkhouri N. Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States. J Clin Gastroenterol. 2018 Apr; 52 (4):339-346
    View PubMed
  101. Charlton M, Rinella M, Patel D, McCague K, Heimbach J, Watt K. Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study. Transplantation. 2017 Dec; 101 (12):2873-2882
    View PubMed
  102. Bhanji RA, Narayanan P, Allen AM, Malhi H, Watt KD. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. Hepatology. 2017 Dec; 66 (6):2055-2065 Epub 2017 Oct 30
    View PubMed
  103. Bazerbachi F, Conboy EE, Mounajjed T, Watt KD, Babovic-Vuksanovic D, Patel SB, Kamath PS. Cryptogenic Cirrhosis and Sitosterolemia: A Treatable Disease If Identified but Fatal If Missed. Ann Hepatol. 2017 Nov - Dec; 16 (6):970-978
    View PubMed
  104. Haffar S, Bazerbachi F, Leise MD, Dillon JJ, Albright RC, Murad MH, Kamath PS, Watt KD. Systematic review with meta-analysis: the association between hepatitis E seroprevalence and haemodialysis. Aliment Pharmacol Ther. 2017 Nov; 46 (9):790-799 Epub 2017 Sept 04
    View PubMed
  105. Bazerbachi F, Conboy EE, Mounajjed T, Watt KD, Babovic-Vuksanovic D, Patel SB, Kamath PS. Cryptogenic Cirrhosis and Sitosterolemia: A Treatable Disease If Identified but Fatal If Missed. Ann Hepatol. 2017 Oct 16; 16 (6):970-978
    View PubMed
  106. Bhanji RA, Carey EJ, Yang L, Watt KD. The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist. Clin Gastroenterol Hepatol. 2017 Oct; 15 (10):1492-1497 Epub 2017 Apr 08
    View PubMed
  107. Bhanji RA, Watt KD. Fatty allograft and cardiovascular outcomes after liver transplantation. Liver Transpl. 2017 Oct; 23 (S1):S76-S80
    View PubMed
  108. Bazerbachi F, Leise MD, Watt KD, Murad MH, Prokop LJ, Haffar S. Systematic review of mixed cryoglobulinemia associated with hepatitis E virus infection: association or causation? Gastroenterol Rep (Oxf). 2017 Aug; 5 (3):178-184 Epub 2017 May 19
    View PubMed
  109. Mouchli MA, Singh S, Loftus EV Jr, Boardman L, Talwalkar J, Rosen CB, Heimbach JK, Wiesner RH, Hasan B, Poterucha JJ, Watt KD, Kymberly WD. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation. 2017 Aug; 101 (8):1859-1866
    View PubMed
  110. Bhanji RA, Carey EJ, Watt KD. Review article: maximising quality of life while aspiring for quantity of life in end-stage liver disease. Aliment Pharmacol Ther. 2017 Jul; 46 (1):16-25 Epub 2017 May 02
    View PubMed
  111. Kittanamongkolchai W, El-Zoghby ZM, Eileen Hay J, Wiesner RH, Kamath PS, LaRusso NF, Watt KD, Cramer CH, Leung N. Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease. Hepatol Int. 2017 Jul; 11 (4):384-389 Epub 2016 Dec 08
    View PubMed
  112. Doycheva I, Watt KD, Alkhouri N. Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic. Hepatology. 2017 Jun; 65 (6):2100-2109 Epub 2017 Apr 28
    View PubMed
  113. Yang JD, Larson JJ, Watt KD, Allen AM, Wiesner RH, Gores GJ, Roberts LR, Heimbach JA, Leise MD. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States. Clin Gastroenterol Hepatol. 2017 May; 15 (5):767-775.e3 Epub 2016 Dec 21
    View PubMed
  114. Doycheva I, Watt KD, Rifai G, Abou Mrad R, Lopez R, Zein NN, Carey WD, Alkhouri N. Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic. Dig Dis Sci. 2017 May; 62 (5):1373-1380 Epub 2017 Feb 13
    View PubMed
  115. Doycheva I, Shaker M, Allende D, Lopez R, Watt KD, Alkhouri N. Low Utility of Noninvasive Fibrosis Scores in Young Adults with Nonalcoholic Fatty Liver Disease. Am J Gastroenterol 2017 Apr; 112 (4):652-653
    View PubMed
  116. Kabbany MN, Conjeevaram Selvakumar PK, Watt K, Lopez R, Akras Z, Zein N, Carey W, Alkhouri N. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. Am J Gastroenterol. 2017 Apr; 112 (4):581-587 Epub 2017 Feb 14
    View PubMed
  117. Haffar S, Bazerbachi F, Prokop L, Watt KD, Murad MH, Chari ST. Frequency and prognosis of acute pancreatitis associated with fulminant or non-fulminant acute hepatitis A: A systematic review. Pancreatology. 2017 Mar-Apr; 17 (2):166-175 Epub 2017 Feb 17
    View PubMed
  118. Nicolas CT, Nyberg SL, Heimbach JK, Watt K, Chen HS, Hathcock MA, Kremers WK. Liver transplantation after share 35: Impact on pretransplant and posttransplant costs and mortality. Liver Transpl. 2017 Jan; 23 (1):11-18 Epub 2016 Dec 05
    View PubMed
  119. Watt KD. The evolving role of the microbiome in liver failure and liver transplantation. Liver Transpl. 2016 Nov; 22 (S1):58-61
    View PubMed
  120. Kasraianfard A, Watt KD, Lindberg L, Alexopoulos S, Rezaei N. HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation. Int Rev Immunol. 2016 Jul 3; 35 (4):312-324 Epub 2014 June 09
    View PubMed
  121. Doycheva I, Amer S, Watt KD. De Novo Malignancies After Transplantation: Risk and Surveillance Strategies. Med Clin North Am. 2016 May; 100 (3):551-67 Epub 2016 Mar 17
    View PubMed
  122. Malhi H, Allen AM, Watt KD. Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival. Curr Opin Organ Transplant. 2016 Apr; 21 (2):99-106
    View PubMed
  123. Doycheva I, Leise MD, Watt KD. The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know. Transplantation. 2016 Jan; 100: (1)61-8.
    View PubMed
  124. Watt KD. Keys to long-term care of the liver transplant recipient. Nat Rev Gastroenterol Hepatol. 2015 Nov; 12 (11):639-48 Epub 2015 Oct 13
    View PubMed
  125. Dhanasekaran R, Sanchez W, Mounajjed T, Wiesner RH, Watt KD, Charlton MR. Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence. Liver Int. 2015 Nov; 35 (11):2433-41 Epub 2015 July 01
    View PubMed
  126. Fussner LA, Iyer VN, Cartin-Ceba R, Lin G, Watt KD, Krowka MJ. Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival. Liver Transpl. 2015 Nov; 21: (11)1355-64.
    View PubMed
  127. Gunneson T, Johnson B, Findlay J, Joyner M, Watt KD. Comparing Cardiopulmonary Exercise Testing in End-Stage Liver Disease Patients. Transplant Proc. 2015 Oct; 47 (8):2470-2
    View PubMed
  128. Aqel BA, Pungpapong S, Leise M, Werner KT, Chervenak AE, Watt KD, Murphy JL, Ryland K, Keaveny AP, McLemore R, Vargas HE. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis. Hepatology. 2015 Oct; 62 (4):1004-12 Epub 2015 Aug 07
    View PubMed
  129. Koning L, Charlton MR, Pas SD, Heimbach JK, Osterhaus AD, Watt KD, Janssen HL, de Knegt RJ, van der Eijk AA. Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States. BMC Infect Dis. 2015 Sep 2; 15:371 Epub 2015 Sept 02
    View PubMed
  130. Charlton M, Everson GT, Flamm SL, Kumar P, Landis C, Brown RS Jr, Fried MW, Terrault NA, O'Leary JG, Vargas HE, Kuo A, Schiff E, Sulkowski MS, Gilroy R, Watt KD, Brown K, Kwo P, Pungpapong S, Korenblat KM, Muir AJ, Teperman L, Fontana RJ, Denning J, Arterburn S, Dvory-Sobol H, Brandt-Sarif T, Pang PS, McHutchison JG, Reddy KR, Afdhal N, SOLAR-1 Investigators. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease. Gastroenterology. 2015 Sep; 149 (3):649-59 Epub 2015 May 15
    View PubMed
  131. Fussner LA, Heimbach JK, Fan C, Dierkhising R, Coss E, Leise MD, Watt KD. Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk. Liver Transpl. 2015 Jul; 21 (7):889-96
    View PubMed
  132. Bhat M, Watt KD. Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk? Clin Transplant. 2015 Jul; 29 (7):654-63 Epub 2015 June 10
    View PubMed
  133. Pungpapong S, Aqel B, Leise M, Werner KT, Murphy JL, Henry TM, Ryland K, Chervenak AE, Watt KD, Vargas HE, Keaveny AP. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant. Hepatology. 2015 Jun; 61 (6):1880-6 Epub 2015 Apr 27
    View PubMed
  134. Sarkar M, Watt KD, Terrault N, Berenguer M. Outcomes in liver transplantation: does sex matter? J Hepatol. 2015 Apr; 62 (4):946-55 Epub 2014 Nov 27
    View PubMed
  135. Pestana L, Swain J, Dierkhising R, Kendrick ML, Kamath PS, Watt KD. Bariatric surgery in patients with cirrhosis with and without portal hypertension: a single-center experience. Mayo Clin Proc. 2015 Feb; 90(2):209-15.
    View PubMed
  136. Fussner LA, Charlton MR, Heimbach JK, Fan C, Dierkhising R, Coss E, Watt KD. The impact of gender and NASH on chronic kidney disease before and after liver transplantation. Liver Int. 2014 Sep; 34(8):1259-66. Epub 2013 Nov 21.
    View PubMed
  137. Watt KD, Fan C, Therneau T, Heimbach JK, Seaberg EC, Charlton MR. Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events. Liver Transpl. 2014 Jul; 20 (7):791-7 Epub 2014 May 26
    View PubMed
  138. Kim DJ, Clark PJ, Heimbach J, Rosen C, Sanchez W, Watt K, Charlton MR. Recurrence of hepatocellular carcinoma: Importance of mRECIST response to chemoembolization and tumor size. Am J Transplant. 2014; 14(6):1383-90.
    View PubMed
  139. Duarte-Rojo A, Budhraja V, Veldt BJ, Goldstein DD, Watt KD, Heimbach JK, McHutchison JG, Tillman HL, Poterucha JJ, Charlton MR. Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review. Liver Transpl. 2013 Dec; 19 (12):1311-7
    View PubMed
  140. Watt KD. Clin Liver Dis (Hoboken). 2013 Nov; 2 (Suppl 5):106-108 Epub 2014 Jan 13
    View PubMed
  141. Watt KD. Extrahepatic implications of metabolic syndrome. Liver Transpl. 2013 Nov; 19 Suppl 2:S56-61
    View PubMed
  142. Watt KD, Dierkhising R, Fan C, Heimbach JK, Tillman H, Goldstein D, Thompson A, Krishnan A, Charlton MR. Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: insight into mechanisms of disease. Am J Transplant. 2013 Sep; 13 (9):2450-7 Epub 2013 July 16
    View PubMed
  143. Guichelaar MM, Gawrieh S, Olivier M, Viker K, Krishnan A, Sanderson S, Malinchoc M, Watt KD, Swain JM, Sarr M, Charlton MR. Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. Obesity (Silver Spring). 2013 Sep; 21 (9):1935-41 Epub 2013 May 29
    View PubMed
  144. Singal AK, Kamath PS, Francisco Ziller N, DiCecco S, Shoreibah M, Kremers W, Charlton MR, Heimbach JK, Watt KD, Shah VH. Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int. 2013 Aug; 26 (8):788-94 Epub 2013 June 11
    View PubMed
  145. Heimbach JK, Watt KD, Poterucha JJ, Ziller NF, Cecco SD, Charlton MR, Hay JE, Wiesner RH, Sanchez W, Rosen CB, Swain JM. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant. 2013 Feb; 13(2):363-8. Epub 2012 Nov 08.
    View PubMed
  146. Chandok N, Watt KD. Burden of de novo malignancy in the liver transplant recipient. Liver Transpl. 2012 Nov; 18(11):1277-89. Epub 2012 Sep 26.
    View PubMed
  147. Watt KD. Reducing the load: the evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation. Liver Transpl. 2012 Nov; 18 Suppl 2:S52-8.
    View PubMed
  148. Watt KD. Liver transplantation and nonalcoholic fatty liver disease. Clin Liver Dis (Hoboken). 2012 Sep; 1 (4):131-133 Epub 2012 Sept 25
    View PubMed
  149. Watt KD, Dierkhising R, Heimbach JK, Charlton MR. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database. Liver Transpl. 2012 Sep; 18(9):1029-36.
    View PubMed
  150. Singh S, Watt KD. Long-term medical management of the liver transplant recipient: what the primary care physician needs to know. Mayo Clin Proc. 2012 Aug; 87 (8):779-90 Epub 2012 July 03
    View PubMed
  151. Duarte-Rojo A, Veldt BJ, Goldstein DD, Tillman HL, Watt KD, Heimbach JK, McHutchison JG, Poterucha JJ, Vargas-Vorackova F, Charlton MR. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables. Transplantation. 2012 Jul 27; 94 (2):197-203
    View PubMed
  152. Levitsky J, Fiel MI, Norvell JP, Wang E, Watt KD, Curry MP, Tewani S, McCashland TM, Hoteit MA, Shaked A, Saab S, Chi AC, Tien A, Schiano TD. Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology. 2012 May; 142(5):1132-1139.e1. Epub 2012 Jan 25.
    View PubMed
  153. Laryea MA, Watt KD. Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation. Liver Transpl. 2012 May; 18(5):514-23.
    View PubMed
  154. Veldt BJ, Duarte-Rojo A, Thompson AJ, Watt KD, Heimbach JK, Tillmann HL, Goldstein DD, McHutchison JG, Charlton MR. Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C. Am J Transplant. 2012 Mar; 12 (3):737-44 Epub 2012 Feb 02
    View PubMed
  155. Koehler E, Swain J, Sanderson S, Krishnan A, Watt K, Charlton M. Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients. Liver Int. 2012 Feb; 32 (2):279-86 Epub 2011 Sept 09
    View PubMed
  156. Weingarten TN, Mantilla CB, Swain JM, Kendrick ML, Oberhansley JM, Burcham RJ, Ribeiro TC, Watt KD, Schroeder DR, Narr BJ, Sprung J. Nonalcoholic steatohepatitis in bariatric patients with a diagnosis of obstructive sleep apnea. Obes Facts. 2012; 5 (4):587-96 Epub 2012 Sept 05
    View PubMed
  157. Watt KD. Metabolic syndrome: is immunosuppression to blame? Liver Transpl. 2011 Nov; 17 Suppl 3:S38-42
    View PubMed
  158. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011 Oct; 141 (4):1249-53 Epub 2011 July 02
    View PubMed
  159. Massoud O, Heimbach J, Viker K, Krishnan A, Poterucha J, Sanchez W, Watt K, Wiesner R, Charlton M. Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay. Liver Transpl. 2011 Jun; 17(6):723-32.
    View PubMed
  160. Ribeireiro T, Swain J, Sarr M, Kendrick M, Que F, Sanderson S, Krishnan A, Viker K, Watt K, Charlton M. NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis. Obes Surg. 2011 Mar; 21 (3):310-5
    View PubMed
  161. Makol A, Watt KD, Chowdhary VR. Autoimmune hepatitis: a review of current diagnosis and treatment. Hepat Res Treat. 2011; 2011:390916 Epub 2011 May 15
    View PubMed
  162. Coss E, Watt KD, Pedersen R, Dierkhising R, Heimbach JK, Charlton MR. Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels. Liver Transpl. 2011 Jan; 17(1):23-31.
    View PubMed
  163. Watt KD, Coss E, Pedersen RA, Dierkhising R, Heimbach JK, Charlton MR. Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation. Liver Transpl. 2010 Aug; 16(8):990-8.
    View PubMed
  164. Watt KD, Charlton MR. Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol. 2010 Jul; 53 (1):199-206 Epub 2010 Mar 31
    View PubMed
  165. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010 Jun; 10 (6):1420-7 Epub 2010 May 10
    View PubMed
  166. Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc. 2010 May; 85 (5):451-8 Epub 2010 Mar 31
    View PubMed
  167. Watt KDS, Chandok N. Safe use of opioids to manage pain in patients with cirrhosis: Reply. Mayo Clin Proc. 2010; 85(10):960.
  168. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Sanchez W, Gores GJ. Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology. 2009 Dec; 137 (6):2010-7 Epub 2009 Sept 18
    View PubMed
  169. Koehler E, Watt K, Charlton M. Fatty liver and liver transplantation. Clin Liver Dis. 2009 Nov; 13(4):621-30.
    View PubMed
  170. Watt K, Veldt B, Charlton M. A practical guide to the management of HCV infection following liver transplantation. Am J Transplant. 2009 Aug; 9 (8):1707-13 Epub 2009 June 16
    View PubMed
  171. Veldt BJ, Poterucha JJ, Watt KD, Wiesner RH, Hay JE, Rosen CB, Heimbach JK, Janssen HL, Charlton MR. Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. Am J Transplant. 2009 Jun; 9 (6):1406-13 Epub 2009 May 13
    View PubMed
  172. Veldt BJ, Poterucha JJ, Watt KD, Wiesner RH, Hay JE, Kremers WK, Rosen CB, Heimbach JK, Charlton MR. Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant. 2008 Nov; 8 (11):2426-33 Epub 2008 Aug 22
    View PubMed
  173. Nudo CG, Yoshida EM, Bain VG, Marleau D, Wong P, Marotta PJ, Renner E, Watt KD, Deschenes M. Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience. Can J Gastroenterol. 2008 Oct; 22(10):821-4.
    View PubMed
  174. Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant. 2008 Mar; 8 (3):667-72
    View PubMed
  175. Watt KD, Burak KW, Deschenes M, Lilly L, Marleau D, Marotta P, Mason A, Peltekian KM, Renner E, Yoshida EM, Canadian Transplant Hepatology Outcomes Research Network. Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada. Can J Gastroenterol. 2008 Feb; 22 (2):153-4
    View PubMed
  176. McCashland T, Watt K, Lyden E, Adams L, Charlton M, Smith AD, McGuire BM, Biggins SW, Neff G, Burton JR Jr, Vargas H, Donovan J, Trotter J, Faust T. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl. 2007 Sep; 13(9):1246-53.
    View PubMed
  177. Laryea M, Watt KD, Molinari M, Walsh MJ, McAlister VC, Marotta PJ, Nashan B, Peltekian KM. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl. 2007 Aug; 13(8):1109-14.
    View PubMed
  178. Watt K, Kives K, Corbin I, Zhang M, Minuk GY. Lack of susceptibility to ischemic necrosis of the remnant liver following partial hepatectomy in the rat. Hepatogastroenterology. 2007 Mar; 54(74):463-5.
    View PubMed
  179. Tulisov A, McMahon BJ, Koch A, Minuk G, Chulanov V, Bruce MG, Uhanova J, Borresen M, Williams J, Osiowy C, Gelvan A, Alexeeva M, Larke B, Watt K. Viral hepatitis in the Arctic. A review from a Circumpolar Workshop on Viral hepatitis, ICCH13. Alaska Med. 2007; 49(2 Suppl):193-203.
    View PubMed
  180. Molinari M, Watt KD, Kruszyna T, Nelson R, Walsh M, Huang WY, Nashan B, Peltekian K. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl. 2006 Dec; 12(12):1892-5.
    View PubMed
  181. Watt KD, Burak K, Deschenes M, Lilly L, Marleau D, Marotta P, Mason A, Peltekian KM, Renner EL, Yoshida EM, Canadian Transplant Hepatology Outcomes Research Network. Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop. Can J Gastroenterol. 2006 Nov; 20(11):725-34.
    View PubMed
  182. Watt KD. Abnormal liver enzymes 2-3 months after liver transplantation in a patient with hepatitis C: Report of a case. Liver Transpl. 2006 Nov; 12(11 Suppl 2):S29-31.
    View PubMed
  183. Singh H, Watt K, Veitch R, Cantor M, Duerksen DR. Malnutrition is prevalent in hospitalized medical patients: are housestaff identifying the malnourished patient? Nutrition. 2006 Apr; 22(4):350-4. Epub 2006 Feb 02.
    View PubMed
  184. Watt KD, Lyden ER, Gulizia JM, McCashland TM. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome. Liver Transpl. 2006 Jan; 12(1):134-9.
    View PubMed
  185. Watt KD, Menke T, Lyden E, McCashland TM. Mortality while awaiting liver retransplantation: predictability of MELD scores. Transplant Proc. 2005 Jun; 37(5):2172-3.
    View PubMed
  186. Watt KD, McCashland TM. Transplantation in the alcoholic patient. Semin Liver Dis. 2004 Aug; 24(3):249-55.
    View PubMed
  187. Watt K, Uhanova J, Gong Y, Kaita K, Doucette K, Pettigrew N, Minuk GY. Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection. J Viral Hepat. 2004 May; 11(3):251-6.
    View PubMed
  188. Belitsky P, Nashan B, Kiberd B, West K, Legare JF, Keough-Ryan T, Watt K. The year in review--2004. Clin Transpl. 2004; 269-301.
    View PubMed
  189. Watt KD, Lyden ER, McCashland TM. Poor survival after liver retransplantation: is hepatitis C to blame? Liver Transpl. 2003 Oct; 9(10):1019-24.
    View PubMed
  190. Watt K, Uhanova J, Minuk GY. Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center. Am J Gastroenterol. 2002 Aug; 97(8):2046-50.
    View PubMed